Hospital and laboratory outcomes of patients with COVID-19 who received vitamin D supplementation: a systematic review and meta-analysis of randomized controlled trials

Coronavirus disease 2019 (COVID-19) has a wide-ranging spectrum of clinical symptoms, from asymptomatic/mild to severe. Recent research indicates that, among several factors, a low vitamin D level is a modifiable risk factor for COVID-19 patients. This study aims to evaluate the effect of vitamin D...

Descripción completa

Detalles Bibliográficos
Autores principales: Zaazouee, Mohamed Sayed, Eleisawy, Mahmoud, Abdalalaziz, Amira M., Elhady, Mahmoud M., Ali, Omar Adel, Abdelbari, Taghreed Mohamed, Hasan, Sara Mohamed, Almadhoon, Hossam Waleed, Ahmed, Alaa Yehia, Fassad, Alaa Shaban, Elgendy, Rewan, Abdel-Baset, Eman Adnan, Elsayed, Hamis A., Elsnhory, Ahmed Bostamy, Abdraboh, Alaa Bahaaeldin, Faragalla, Hazem Metwally, Elshanbary, Alaa Ahmed, Kensara, Osama A., Abdel-Daim, Mohamed M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743115/
https://www.ncbi.nlm.nih.gov/pubmed/36508011
http://dx.doi.org/10.1007/s00210-022-02360-x
_version_ 1784848663877517312
author Zaazouee, Mohamed Sayed
Eleisawy, Mahmoud
Abdalalaziz, Amira M.
Elhady, Mahmoud M.
Ali, Omar Adel
Abdelbari, Taghreed Mohamed
Hasan, Sara Mohamed
Almadhoon, Hossam Waleed
Ahmed, Alaa Yehia
Fassad, Alaa Shaban
Elgendy, Rewan
Abdel-Baset, Eman Adnan
Elsayed, Hamis A.
Elsnhory, Ahmed Bostamy
Abdraboh, Alaa Bahaaeldin
Faragalla, Hazem Metwally
Elshanbary, Alaa Ahmed
Kensara, Osama A.
Abdel-Daim, Mohamed M.
author_facet Zaazouee, Mohamed Sayed
Eleisawy, Mahmoud
Abdalalaziz, Amira M.
Elhady, Mahmoud M.
Ali, Omar Adel
Abdelbari, Taghreed Mohamed
Hasan, Sara Mohamed
Almadhoon, Hossam Waleed
Ahmed, Alaa Yehia
Fassad, Alaa Shaban
Elgendy, Rewan
Abdel-Baset, Eman Adnan
Elsayed, Hamis A.
Elsnhory, Ahmed Bostamy
Abdraboh, Alaa Bahaaeldin
Faragalla, Hazem Metwally
Elshanbary, Alaa Ahmed
Kensara, Osama A.
Abdel-Daim, Mohamed M.
author_sort Zaazouee, Mohamed Sayed
collection PubMed
description Coronavirus disease 2019 (COVID-19) has a wide-ranging spectrum of clinical symptoms, from asymptomatic/mild to severe. Recent research indicates that, among several factors, a low vitamin D level is a modifiable risk factor for COVID-19 patients. This study aims to evaluate the effect of vitamin D on hospital and laboratory outcomes of patients with COVID-19. Five databases (PubMed, Embase, Scopus, Web of Science, and Cochrane Library) and clinicaltrials.gov were searched until July 2022, using relevant keywords/Mesh terms. Only randomized clinical trials (RCTs) that addressed the topic were included. The Cochrane tool was used to assess the studies’ risk of bias, and the data were analyzed using the review manager (RevMan 5.4). We included nine RCTs with 1586 confirmed COVID-19 patients. Vitamin D group showed a significant reduction of intensive care unit (ICU) admission (risk ratio = 0.59, 95% confidence interval (CI) [0.41, 0.84], P = 0.003), and higher change in vitamin D level (standardized mean difference = 2.27, 95% CI [2.08, 2.47], P < 0.00001) compared to the control group. Other studied hospital and laboratory outcomes showed non-significant difference between vitamin D and the control group (P ≥ 0.05). In conclusion, vitamin D reduced the risk of ICU admission and showed superiority in changing vitamin D level compared to the control group. However, other outcomes showed no difference between the two groups. More RCTs are needed to confirm these results. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00210-022-02360-x.
format Online
Article
Text
id pubmed-9743115
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-97431152022-12-13 Hospital and laboratory outcomes of patients with COVID-19 who received vitamin D supplementation: a systematic review and meta-analysis of randomized controlled trials Zaazouee, Mohamed Sayed Eleisawy, Mahmoud Abdalalaziz, Amira M. Elhady, Mahmoud M. Ali, Omar Adel Abdelbari, Taghreed Mohamed Hasan, Sara Mohamed Almadhoon, Hossam Waleed Ahmed, Alaa Yehia Fassad, Alaa Shaban Elgendy, Rewan Abdel-Baset, Eman Adnan Elsayed, Hamis A. Elsnhory, Ahmed Bostamy Abdraboh, Alaa Bahaaeldin Faragalla, Hazem Metwally Elshanbary, Alaa Ahmed Kensara, Osama A. Abdel-Daim, Mohamed M. Naunyn Schmiedebergs Arch Pharmacol Review Coronavirus disease 2019 (COVID-19) has a wide-ranging spectrum of clinical symptoms, from asymptomatic/mild to severe. Recent research indicates that, among several factors, a low vitamin D level is a modifiable risk factor for COVID-19 patients. This study aims to evaluate the effect of vitamin D on hospital and laboratory outcomes of patients with COVID-19. Five databases (PubMed, Embase, Scopus, Web of Science, and Cochrane Library) and clinicaltrials.gov were searched until July 2022, using relevant keywords/Mesh terms. Only randomized clinical trials (RCTs) that addressed the topic were included. The Cochrane tool was used to assess the studies’ risk of bias, and the data were analyzed using the review manager (RevMan 5.4). We included nine RCTs with 1586 confirmed COVID-19 patients. Vitamin D group showed a significant reduction of intensive care unit (ICU) admission (risk ratio = 0.59, 95% confidence interval (CI) [0.41, 0.84], P = 0.003), and higher change in vitamin D level (standardized mean difference = 2.27, 95% CI [2.08, 2.47], P < 0.00001) compared to the control group. Other studied hospital and laboratory outcomes showed non-significant difference between vitamin D and the control group (P ≥ 0.05). In conclusion, vitamin D reduced the risk of ICU admission and showed superiority in changing vitamin D level compared to the control group. However, other outcomes showed no difference between the two groups. More RCTs are needed to confirm these results. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00210-022-02360-x. Springer Berlin Heidelberg 2022-12-12 2023 /pmc/articles/PMC9743115/ /pubmed/36508011 http://dx.doi.org/10.1007/s00210-022-02360-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Review
Zaazouee, Mohamed Sayed
Eleisawy, Mahmoud
Abdalalaziz, Amira M.
Elhady, Mahmoud M.
Ali, Omar Adel
Abdelbari, Taghreed Mohamed
Hasan, Sara Mohamed
Almadhoon, Hossam Waleed
Ahmed, Alaa Yehia
Fassad, Alaa Shaban
Elgendy, Rewan
Abdel-Baset, Eman Adnan
Elsayed, Hamis A.
Elsnhory, Ahmed Bostamy
Abdraboh, Alaa Bahaaeldin
Faragalla, Hazem Metwally
Elshanbary, Alaa Ahmed
Kensara, Osama A.
Abdel-Daim, Mohamed M.
Hospital and laboratory outcomes of patients with COVID-19 who received vitamin D supplementation: a systematic review and meta-analysis of randomized controlled trials
title Hospital and laboratory outcomes of patients with COVID-19 who received vitamin D supplementation: a systematic review and meta-analysis of randomized controlled trials
title_full Hospital and laboratory outcomes of patients with COVID-19 who received vitamin D supplementation: a systematic review and meta-analysis of randomized controlled trials
title_fullStr Hospital and laboratory outcomes of patients with COVID-19 who received vitamin D supplementation: a systematic review and meta-analysis of randomized controlled trials
title_full_unstemmed Hospital and laboratory outcomes of patients with COVID-19 who received vitamin D supplementation: a systematic review and meta-analysis of randomized controlled trials
title_short Hospital and laboratory outcomes of patients with COVID-19 who received vitamin D supplementation: a systematic review and meta-analysis of randomized controlled trials
title_sort hospital and laboratory outcomes of patients with covid-19 who received vitamin d supplementation: a systematic review and meta-analysis of randomized controlled trials
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743115/
https://www.ncbi.nlm.nih.gov/pubmed/36508011
http://dx.doi.org/10.1007/s00210-022-02360-x
work_keys_str_mv AT zaazoueemohamedsayed hospitalandlaboratoryoutcomesofpatientswithcovid19whoreceivedvitamindsupplementationasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT eleisawymahmoud hospitalandlaboratoryoutcomesofpatientswithcovid19whoreceivedvitamindsupplementationasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT abdalalazizamiram hospitalandlaboratoryoutcomesofpatientswithcovid19whoreceivedvitamindsupplementationasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT elhadymahmoudm hospitalandlaboratoryoutcomesofpatientswithcovid19whoreceivedvitamindsupplementationasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT aliomaradel hospitalandlaboratoryoutcomesofpatientswithcovid19whoreceivedvitamindsupplementationasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT abdelbaritaghreedmohamed hospitalandlaboratoryoutcomesofpatientswithcovid19whoreceivedvitamindsupplementationasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT hasansaramohamed hospitalandlaboratoryoutcomesofpatientswithcovid19whoreceivedvitamindsupplementationasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT almadhoonhossamwaleed hospitalandlaboratoryoutcomesofpatientswithcovid19whoreceivedvitamindsupplementationasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT ahmedalaayehia hospitalandlaboratoryoutcomesofpatientswithcovid19whoreceivedvitamindsupplementationasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT fassadalaashaban hospitalandlaboratoryoutcomesofpatientswithcovid19whoreceivedvitamindsupplementationasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT elgendyrewan hospitalandlaboratoryoutcomesofpatientswithcovid19whoreceivedvitamindsupplementationasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT abdelbasetemanadnan hospitalandlaboratoryoutcomesofpatientswithcovid19whoreceivedvitamindsupplementationasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT elsayedhamisa hospitalandlaboratoryoutcomesofpatientswithcovid19whoreceivedvitamindsupplementationasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT elsnhoryahmedbostamy hospitalandlaboratoryoutcomesofpatientswithcovid19whoreceivedvitamindsupplementationasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT abdrabohalaabahaaeldin hospitalandlaboratoryoutcomesofpatientswithcovid19whoreceivedvitamindsupplementationasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT faragallahazemmetwally hospitalandlaboratoryoutcomesofpatientswithcovid19whoreceivedvitamindsupplementationasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT elshanbaryalaaahmed hospitalandlaboratoryoutcomesofpatientswithcovid19whoreceivedvitamindsupplementationasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT kensaraosamaa hospitalandlaboratoryoutcomesofpatientswithcovid19whoreceivedvitamindsupplementationasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT abdeldaimmohamedm hospitalandlaboratoryoutcomesofpatientswithcovid19whoreceivedvitamindsupplementationasystematicreviewandmetaanalysisofrandomizedcontrolledtrials